“Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from Two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies”. SKIN The Journal of Cutaneous Medicine, vol. 3, no. 2, Mar. 2019, p. 161, https://doi.org/10.25251/skin.3.2.1.